Managing Antidepressant Discontinuation: A Systematic Review
- PMID: 30670397
- PMCID: PMC6342590
- DOI: 10.1370/afm.2336
Managing Antidepressant Discontinuation: A Systematic Review
Abstract
Purpose: We aimed to determine the effectiveness of interventions to manage antidepressant discontinuation, and the outcomes for patients.
Methods: We conducted a systematic review with narrative synthesis and meta-analysis of studies published to March 2017. Studies were eligible for inclusion if they were randomized controlled trials, quasi-experimental studies, or observational studies assessing interventions to facilitate discontinuation of antidepressants for depression in adults. Our primary outcomes were antidepressant discontinuation and discontinuation symptoms. Secondary outcomes were relapse/recurrence; quality of life; antidepressant reduction; and sexual, social, and occupational function.
Results: Of 15 included studies, 12 studies (8 randomized controlled trials, 2 single-arm trials, 2 retrospective cohort studies) were included in the synthesis. None were rated as having high risk for selection or detection bias. Two studies prompting primary care clinician discontinuation with antidepressant tapering guidance found 6% and 7% of patients discontinued, vs 8% for usual care. Six studies of psychological or psychiatric treatment plus tapering reported cessation rates of 40% to 95%. Two studies reported a higher risk of discontinuation symptoms with abrupt termination. At 2 years, risk of relapse/recurrence was lower with cognitive behavioral therapy plus taper vs clinical management plus taper (15% to 25% vs 35% to 80%: risk ratio = 0.34; 95% CI, 0.18-0.67; 2 studies). Relapse/recurrence rates were similar for mindfulness-based cognitive therapy with tapering and maintenance antidepressants (44% to 48% vs 47% to 60%; 2 studies).
Conclusions: Cognitive behavioral therapy or mindfulness-based cognitive therapy can help patients discontinue antidepressants without increasing the risk of relapse/recurrence, but are resource intensive. More scalable interventions incorporating psychological support are needed.
Keywords: antidepressants; deprescribing; depression; discontinuation syndrome; mental health; prescribing; primary care.
© 2019 Annals of Family Medicine, Inc.
Comment in
-
Antidepressant discontinuation can be problematic for patients but relapse rates might be reduced with cognitive behavioural therapy or mindfulness-based cognitive therapy.Evid Based Nurs. 2019 Oct;22(4):112. doi: 10.1136/ebnurs-2019-103085. Epub 2019 Apr 4. Evid Based Nurs. 2019. PMID: 30948434 No abstract available.
Similar articles
-
Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults.Cochrane Database Syst Rev. 2021 Apr 15;4(4):CD013495. doi: 10.1002/14651858.CD013495.pub2. Cochrane Database Syst Rev. 2021. PMID: 33886130 Free PMC article.
-
Discontinuation of antidepressant medication in primary care supported by monitoring plus mindfulness-based cognitive therapy versus monitoring alone: design and protocol of a cluster randomized controlled trial.BMC Fam Pract. 2019 Jul 26;20(1):105. doi: 10.1186/s12875-019-0989-5. BMC Fam Pract. 2019. PMID: 31349796 Free PMC article.
-
The effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse/recurrence: results of a randomised controlled trial (the PREVENT study).Health Technol Assess. 2015 Sep;19(73):1-124. doi: 10.3310/hta19730. Health Technol Assess. 2015. PMID: 26379122 Free PMC article. Clinical Trial.
-
Adjuvant therapy with antidepressants for the management of inflammatory bowel disease.Cochrane Database Syst Rev. 2019 Apr 12;4(4):CD012680. doi: 10.1002/14651858.CD012680.pub2. Cochrane Database Syst Rev. 2019. PMID: 30977111 Free PMC article.
-
Risk of relapse after antidepressant discontinuation in anxiety disorders, obsessive-compulsive disorder, and post-traumatic stress disorder: systematic review and meta-analysis of relapse prevention trials.BMJ. 2017 Sep 13;358:j3927. doi: 10.1136/bmj.j3927. BMJ. 2017. PMID: 28903922 Free PMC article. Review.
Cited by
-
Clinical practice guideline recommendations on tapering and discontinuing antidepressants for depression: a systematic review.Ther Adv Psychopharmacol. 2022 Feb 11;12:20451253211067656. doi: 10.1177/20451253211067656. eCollection 2022. Ther Adv Psychopharmacol. 2022. PMID: 35173954 Free PMC article. Review.
-
Evaluating the Clinical Feasibility of an Artificial Intelligence-Powered, Web-Based Clinical Decision Support System for the Treatment of Depression in Adults: Longitudinal Feasibility Study.JMIR Form Res. 2021 Oct 25;5(10):e31862. doi: 10.2196/31862. JMIR Form Res. 2021. PMID: 34694234 Free PMC article.
-
The relationship between dose and serotonin transporter occupancy of antidepressants-a systematic review.Mol Psychiatry. 2022 Jan;27(1):192-201. doi: 10.1038/s41380-021-01285-w. Epub 2021 Sep 21. Mol Psychiatry. 2022. PMID: 34548628 Free PMC article. Review.
-
Deprescribing for all: a narrative review identifying inappropriate polypharmacy for all ages in hospital settings.BMJ Open Qual. 2021 Jul;10(3):e001509. doi: 10.1136/bmjoq-2021-001509. BMJ Open Qual. 2021. PMID: 34230053 Free PMC article. Review. No abstract available.
-
Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults.Cochrane Database Syst Rev. 2021 Apr 15;4(4):CD013495. doi: 10.1002/14651858.CD013495.pub2. Cochrane Database Syst Rev. 2021. PMID: 33886130 Free PMC article.
Publication types
MeSH terms
Substances
Grant support
LinkOut - more resources
Full Text Sources
Medical